Interview with André Syrota, Director – General, INSERM –…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
Expanscience is a family owned, independent French pharmaceutical and dermo-cosmetics laboratory, developing and manufacturing innovative osteoarthritis and skincare products. The company’s products, including two leading brands including Piascledine 300 and Mustela, are sold in more than 100 countries. With over 60 years of experience, Expanscience has built up a solid international reputation as an innovator and a specialist. The company prides itself in developing and marketing with active ingredients of natural origin for the French and international cosmetics industry. Thanks to a robust Corporate Social Responsibility program introduced over ten years ago, the company has made strong efforts in developing a sustainable and environmentally conscious business practice which has been recognized as exemplary by the AFAQ 26000 assessment in 2013. With a company motto: “Protecting Your Health Through Innovation,” Expanscience innovates to develop safe and effective solutions that do not harm people or the environment so that everyone can avoid osteoarthritis and skin problems.
Contact
10 avenue de l’Arche
92419 – Courbevoie
France
Tel : +33 (0)1 43 34 60 00
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical companies developing products for the pharmaceutical sector. To what degree…
France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like? I have spent half…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the French model rewards innovative…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that…
See our Cookie Privacy Policy Here
